Benefity vyšetření 18F-FET PET v předoperačním posouzení heterogenity gliálních tumorů demonstrovány na dvou kazuistikách

Stáhnout PDF English version

Autoři: H. Valeková ^1,2; J. Vašina ³; Z. Řehák ³; M. Hodolic ^4,5; M. Hendrych ^6,7; T. Kazda ⁸; P. Pospíšil ⁸ ; P. Solár ^1,2; Z. Mackerle ^1,2; R. Jančálek ^1,2
Působiště autorů: Department of Neurosurgery –, St. Anne’s University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic ¹; Department of Neurosurgery, St. Anne’s, University Hospital Brno, Brno, Czech, Republic ²; Department of Nuclear Medicine and, PET Center, Masaryk Memorial Cancer, Institute and Faculty of Medicine, Masaryk, University, Brno, Czech Republic ³; Nuclear Medicine Research Department, IASON, Graz, Austria ⁴; Department of Nuclear Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic ⁵; First Department of Pathology, Faculty, of Medicine, Masaryk University, Brno, Czech Republic ⁶; First Department of Pathology, St. Anne’s University Hospital, Brno, Czech Republic ⁷; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic ⁸
Vyšlo v časopise: Cesk Slov Neurol N 2021; 84/117(4): 405-409
Kategorie: Dopisy redakci
doi: https://doi.org/10.48095/cccsnn2021405

Zdroje

1. la Fougere C, Suchorska B, Bartenstein P et al. Molecular imaging of gliomas with PET: opportunities and limitations. Neuro Oncol 2011; 13(8): 806–819. doi: 10.1093/neuonc/nor054.

2. Del Sole A, Falini A, Ravasi L et al. Anatomical and biochemical investigation of primary brain tumours. Eur J Nucl Med 2001; 28(12): 1851–1872. doi: 10.1007/s002590100604.

3. Miyagawa T, Oku T, Uehara H et al. “Facilitated” amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab 1998; 18(5): 500–509. doi: 10.1097/00004647-199805000-00005.

4. Bading JR, Kan-Mitchell J, Conti PS. System A amino acid transport in cultured human tumor cells: implications for tumor imaging with PET. Nucl Med Biol 1996; 23(6): 779–786. doi: 10.1016/0969-8051(96)00073-x.

5. Heiss W-D. Clinical impact of amino acid PET in gliomas. J Nucl Med 2014; 55(8): 1219–1220. doi: 10.2967/jnumed.114.142661.

6. Wyss MT, Spaeth N, Biollaz G et al. Uptake of 18F-fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis. J Nucl Med 2007; 48(4): 608–614. doi: 10.2967/jnumed.106.036251.

7. Langen K-J, Hamacher K, Weckesser M et al. O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2006; 33(3): 287–294. doi: 10.1016/j.nucmedbio.2006.01.002.

8. Saga T, Kawashima H, Araki N et al. Evaluation of primary brain tumors with FLT-PET: usefulness and limitations. Clin Nucl Med 2006; 31(12): 774–780. doi: 10.1097/01.rlu.0000246820.14892.d2.

9. Salskov A, Tammisetti VS, Grierson J et al. FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3’-deoxy-3’-[18F]fluorothymidine. Semin Nucl Med 2007; 37(6): 429–439. doi: 10.1053/j.semnuclmed.2007.08.001.

10. Galldiks N, Lohmann P, Albert NL et al. Current status of PET imaging in neuro-oncology. Neurooncol Adv 2019; 1(1): vdz010. doi: 10.1093/noajnl/vdz010.